We have previously reported that there is a poor correlation between increase in the levels of UDP-glucuronosyltransferases, UGT1A1 and UGT1A6, and decrease in the levels of serum total thyroxine (T 4 ) and free T 4 in phenobarbital (PB)-treated rats, although the PB-induced decrease in rats is generally thought to occur through induction of the UDP-glucuronosyltransferase (T 4 -UDP-GT: UGT1A1 and UGT1A6). In the present study, to clarify a relationship between the decrease in serum T 4 level and the increase in the T 4 -UDP-GT activity by PB in rats, we examined the relationship using Gunn rats, a mutant strain of Wistar rats deficient in UGT1A isoforms. Levels of serum total T 4 , free T 4 , and total triiodothyronine (T 3 ) were markedly decreased not only in Wistar rats but also in Gunn rats 1 day after the final administration of PB (80 mg/kg i.p., once daily for 4 days), and no significant difference in magnitude of the decrease between Wistar and Gunn rats was observed. On the other hand, the level and activity of T 4 -UDP-GT were significantly increased by treatment with PB in Wistar rats but not in Gunn rats. Furthermore, significant decrease in the activity of hepatic type I iodothyronine deiodinase, which mediates the deiodination of T 4 and T 3 , by PB treatment was observed in both Wistar and Gunn rats. In addition, no significant change in the level of serum thyroid-stimulating hormone, the activity of hepatic sulfotransferase, and the binding of Phenobarbital (PB) is well known to decrease the level of serum thyroid hormone and to increase the activities of hepatic drug-metabolizing enzymes in rats and mice (O'Connor et al., 1999; Hood et al., 2003) . Furthermore, PB increases levels of serum thyroid-stimulating hormone (TSH) and thyroid gland growth in rats . As a possible mechanism for the PB-induced decrease in the level of serum thyroid hormone, enhancement of thyroid hormone metabolism by PB is considered (McClain, 1989; Capen, 1997) . Especially, the decrease in the level of serum thyroxine (T 4 ) by PB in rats is thought to occur mainly through the induction of T 4 -UDP-glucuronosyltransferase (T 4 -UDP-GT), responsible for glucuronidation of T 4 (Barter and Klaassen, 1992a; Liu et al., 1995) . This hypothesis is supported by the previous reports that a number of T 4 -UDP-GT inducers, such as polychlorinated biphenyl (PCB), 3-methylcholanthrene, and pregnenolone-16␣-carbonitrile, show the ability to decrease serum thyroid hormone (Saito et al., 1991; De Sandro et al., 1992; Barter and Klaassen, 1994) . However, the magnitude of decrease in the level of serum total T 4 by PB is not necessarily correlated with that of increase in T 4 -UDP-GT activity (Saito et al., 1991; Hood et al., 2003) . Likewise, our preliminary study has indicated that there is a poor correlation between increase in the levels of UGT1A1 and UGT1A6 and decrease in the levels of serum total T 4 and free T 4 in PB-treated rats.
albumin by PB treatment was observed in either Wistar or Gunn rats. In conclusion, the present results demonstrate that the decrease in serum total T 4 level by PB in Gunn rats is not dependent on the increase in hepatic T 4 -UDP-GT activity and suggest that even in Wistar rats, the PB-induced decrease in serum T 4 level does not occur only through increase in hepatic T 4 -UDP-GT.
Phenobarbital (PB) is well known to decrease the level of serum thyroid hormone and to increase the activities of hepatic drug-metabolizing enzymes in rats and mice (O'Connor et al., 1999; Hood et al., 2003) . Furthermore, PB increases levels of serum thyroid-stimulating hormone (TSH) and thyroid gland growth in rats . As a possible mechanism for the PB-induced decrease in the level of serum thyroid hormone, enhancement of thyroid hormone metabolism by PB is considered (McClain, 1989; Capen, 1997) . Especially, the decrease in the level of serum thyroxine (T 4 ) by PB in rats is thought to occur mainly through the induction of T 4 -UDP-glucuronosyltransferase (T 4 -UDP-GT), responsible for glucuronidation of T 4 (Barter and Klaassen, 1992a; Liu et al., 1995) . This hypothesis is supported by the previous reports that a number of T 4 -UDP-GT inducers, such as polychlorinated biphenyl (PCB), 3-methylcholanthrene, and pregnenolone-16␣-carbonitrile, show the ability to decrease serum thyroid hormone (Saito et al., 1991; De Sandro et al., 1992; Barter and Klaassen, 1994) . However, the magnitude of decrease in the level of serum total T 4 by PB is not necessarily correlated with that of increase in T 4 -UDP-GT activity (Saito et al., 1991; Hood et al., 2003) . Likewise, our preliminary study has indicated that there is a poor correlation between increase in the levels of UGT1A1 and UGT1A6 and decrease in the levels of serum total T 4 and free T 4 in PB-treated rats.
In the present study, therefore, we examined a relationship between the decrease in serum total T 4 level and the increase in hepatic T 4 -UDP-GT (UGT1A1 and UGT1A6) by PB using UGT1A-deficient Wistar rats (Gunn rats) and demonstrated that the PB-induced decrease in serum total T 4 level in rats was not necessarily dependent on the increase in hepatic T 4 -UDP-GT activity.
Materials and Methods
Chemicals. PB was purchased from Nakakita Yakuhin Co., Ltd. (Aichi, Japan). The 125 I-reverse triiodothyronine (T 3 ) and [ 125 I]T 4 , radiolabeled at the 5Ј-position of the outer ring, was obtained from PerkinElmer Life and Analytical Sciences (Boston, MA). All other chemicals were obtained commercially in appropriate grades of purity.
Animal Treatments. Male Wistar rats (160 -200 g) and UGT1A-deficient Wistar rats (Gunn rats, were obtained from Japan SLC., Inc.
(Shizuoka, Japan). Male Wistar and Gunn rats were housed three or four per cage with free access to commercial chow and tap water, maintained on a 12-h dark/light cycle (8:00 AM-8:00 PM light) in an air-controlled room (temperature, 24.5 Ϯ 1°C; humidity, 55 Ϯ 5%), and handled with humane care under the guidelines of the University of Shizuoka (Shizuoka, Japan). Rats received four consecutive intraperitoneal injections of PB (80 mg/kg) dissolved in 0.9% saline (5 ml/kg). Control animals were treated with a vehicle alone (5 ml/kg). All rats were killed by decapitation 1 day after the final administration. The liver was removed, and hepatic microsomes and cytosols were prepared according to the method of Kato et al. (1995) and stored at Ϫ85°C until used. Blood was collected from each animal between 10:30 and 11:30 AM. After clotting at room temperature, serum was separated by centrifugation and stored at Ϫ50°C until used.
Analysis of Serum Hormones. Levels of serum total T 4 , free T 4 , total T 3 , and TSH were measured by radioimmunoassay using the Total T4 and Free T4 kit (Diagnostic Products Corporation, Los Angels, CA), the T-3 ⅐ RIABEAD (Abbott Japan Co., Ltd., Tokyo, Japan), and the rTSH [
125 I] Biotrak assay system (Amersham Biosciences UK, Ltd., Little Chalfont, Buckinghamshire, UK), respectively.
Hepatic T 4 -Metabolizing Enzyme Assays. Amounts of proteins of hepatic subcellular fractions, microsomes and cytosols, were determined by the method of Lowry et al. (1951) with bovine serum albumin as a standard. The activity of microsomal UDP-GT toward T 4 was determined by the method of Barter and Klaassen (1992b) . The activity of microsomal type I iodothyronine deiodinase (ID-I) was determined by the method of Hood and Klaassen (2000) . The activity of cytosolic sulfotransferase toward T 4 was determined by the method of Kaptein et al. (1997) .
Western Blot Analysis. Polyclonal anti-peptide antibodies against the common region of UGT1A isoforms and specific antibodies against UGT1A1, UGT1A6, and UGT2B1 were used (Ikushiro et al., 1995 (Ikushiro et al., , 1997 . Western blot analyses for microsomal UGT isoforms were performed by the method of Luquita et al. (2001) . Isolated proteins corresponding to UGT1A1, UGT1A6, and UGT2B1 were detected using chemical luminescence (ECL detection kit; Amersham Biosciences Inc., Piscataway, NJ), and the level of each protein was determined densitometrically with LAS-1000 (Fuji Photo Film Co., Ltd., Toyko, Japan).
Analysis of [ 125 I]T 4 Binding to Serum Proteins. At 1 day after a consecutive 4-day treatment with PB, rats were anesthetized with 50 mg/ml sodium pentobarbital combined 1:1 with 1 mg/ml potassium iodide at 2 mg/ml. The femoral artery was cannulated (polyethylene tube SP31; Natume Inc., Tokyo, Japan) and primed with heparinized saline (33 units/ml). Fifteen minutes later, rats were given 1 ml of [ 125 I]T 4 i.v., at 15 Ci/ml in 10 mM NaOH saline ϩ 1% normal rat serum. After the administration of [ 125 I]T 4 , a portion (0.3 ml) of blood was sampled from the artery at the indicated time, and serum was collected and stored at Ϫ50°C for assay. Serum was diluted in 100 mM phosphate buffer (pH 7.4) containing 1 mM EDTA, 1 mM dithiothreitol, and 30% glycerol, and subjected to electrophoresis on 4 to 20% gradient native polyacrylamide gels PAG Mid "Daiichi" 4/20 (Daiichi Pure Chemicals Co., Ltd., Tokyo, Japan), using 0.025 M Tris (pH 8.4) containing 0.192 M glycine as running buffer, for 11 h at 20 mA at 4°C. Human albumin and transthyretin (TTR), which were incubated with [
125 I]T 4 , were also applied on the gel as templates. After the electrophoresis, a gel was dried and radioautographed for 20 h at room temperature using Imaging Plate 2040 (Fuji Photo Film Co., Ltd). 
Results
Serum Hormone Levels. Constitutive levels of serum total T 4 , free T 4 , total T 3, and TSH were more than 1.8-fold higher in Gunn rats than in Wistar rats. Effects of PB on levels of serum thyroid hormones were next examined in Wistar and Gunn rats (Fig. 1) . In both Wistar and Gunn rats, PB treatment resulted in decreases of serum total T 4 , free T 4 , and total T 3 , and the magnitude of the decrease in each serum thyroid hormone was almost the same in both rats. On the other hand, no significant change in the level of serum TSH by PB treatment was observed in either Wistar or Gunn rats.
Hepatic T 4 -Metabolizing Enzyme Activities. It has been reported that T 4 glucuronidation is primarily mediated by UGT1A enzymes, UGT1A1 and UGT1A6, in the rat liver (Visser, 1996) . Therefore, we examined effects of PB on hepatic microsomal T 4 -UDP-GT activity in Wistar and Gunn rats. Constitutive activity of T 4 -UDP-GT was more than 2.1-fold higher in Wistar rats than in Gunn rats. PB treatment resulted in a significant increase of T 4 -UDP-GT activity in Wistar rats but not in Gunn rats (Fig. 2) .
Hepatic microsomal ID-I activity in both Wistar and Gunn rats was significantly decreased by PB (Fig. 3) . On the other hand, no significant change in activity of hepatic sulfotransferase by PB treatment was observed in either PB-treated Wistar or Gunn rats (data not shown).
FIG. 1. Effect of PB on levels of serum total thyroxine (T 4 ), free T 4 , total triiodothyronine (T 3 ), and TSH. Animals were killed 1 day after the final administration of PB (80 mg/kg i.p., once daily for 4 days), and levels of serum thyroid hormones were measured as described under Materials and Methods. Constitutive levels: total T 4 , 3.32 Ϯ 0.21 (Wistar, N ϭ 7) and 7.99 Ϯ 0.30 g/dl (Gunn, N ϭ 4); free T 4 , 1.54 Ϯ 0.07 (Wistar, N ϭ 7) and 2.77 Ϯ 0.07 ng/dl (Gunn, N ϭ 4); total T 3 , 0.34 Ϯ 0.03 (Wistar, N ϭ 6) and 0.96 Ϯ 0.05 ng/ml (Gunn, N ϭ 4); TSH, 8.37 Ϯ 1.25 (Wistar, N ϭ 6) and 20.85 Ϯ 1.79 ng/ml (Gunn, N ϭ 4). Each column represents the mean Ϯ S.E. (vertical bars) for four to seven animals. ‫,ء‬ P Ͻ 0.01, significantly different from each control.
Immunoblot Analysis for UGT1As. Levels of immunoreactive proteins responsible for UGT1A isoforms, UGT1A1 and UGT1A6, were increased by PB in Wistar rats but not in Gunn rats (Figs. 4 and 5) . In addition, no constitutive expression of the UGT1A isoforms was confirmed in Gunn rats. On the other hand, the level of UGT2B1 was significantly increased by PB in both Wistar and Gunn rats, and the magnitude of the increase was higher in Gunn rats than in Wistar rats (Figs. 4 and 5 (Fig. 6) .
Discussion
In the present study, we found that treatment with PB resulted in a drastic decrease in serum total T 4 and free T 4 levels in both Wistar and Gunn rats, although significant increase in the activity of T 4 -UDP-GT occurred only in Wistar rats and not in Gunn rats. The present findings demonstrate that in Gunn rats, PB-induced decrease in the level of serum T 4 occurs in a hepatic T 4 -UDP-GT-independent fashion. In addition, constitutive levels of serum total T 4 and T 3 were more than 1.8-fold higher in Gunn rats than in Wistar rats, suggesting that the deficit of T 4 glucuronidation results in higher T 4 serum levels. Similar results and suggestions have been obtained by Benathan et al. (1983) .
In general, T 4 -UDP-GT inducers, including PB, clobazam, PCB, 3-methylcholanthrene, and pregnenolone-16␣-carbonitrile, have been considered to decrease a level of serum T 4 through an increase in hepatic T 4 -UDP-GT (Barter and Klaassen, 1994; Van Birgelen et al., 1995; Miyawaki et al., 2003) . However, it has been reported that the difference between rats and mice in the magnitude of decrease in the level of serum total T 4 by an inducer of T 4 -UDP-GT is not well correlated with that of the increase in activity of T 4 -UDP-GT (Craft et al., 2002; Hood et al., 2003) . Furthermore, we have reported previously that the PCB-induced decrease in serum T 4 level might occur not only through the increase in hepatic T 4 -UDP-GT activity but also via formation of hydroxylated PCB metabolites in rats and that in PB-treated rats, there was a poor correlation between the increase in the levels of UGT1A1 and UGT1A6 and the decrease in the levels of serum total T 4 and free T 4 . These previous reports strongly support a possibility that the decrease in serum total T 4 level by PB does not occur only through an increase in hepatic T 4 -UDP-GT activity.
As possible mechanisms for the PB-induced decrease in serum T 4 level, changes in hepatic ID-I activity and serum TSH level might be considered. However, a significant decrease in activity of hepatic ID-I, which mediates the deiodination of T 4 and T 3 , by PB treatment was observed in both Wistar and Gunn rats. Similar results have been reported in PB-treated Sprague-Dawley rats (O'Connor et al., 1999; Hood and Klaassen, 2000) . Accordingly, the PB-induced decrease in serum T 4 level is thought to occur through an ID-I-independent pathway. Furthermore, in the present study, levels of serum TSH in both Wistar and Gunn rats were not significantly changed by PB, indicating that TSH is not related to the PB-induced decrease in serum T 4 level, although a significant increase in serum TSH level has been reported to occur in PB-treated rats O'Connor et al., 1999) . The difference between the previous results and our present results might be attributed to the difference in the dose examined.
Although it has been reported that the binding of PCB and its hydroxylated metabolites to TTR, a major T 4 -transporting protein, might be attributed, in part, to a decrease in the level of serum T 4 in PCB-treated rats (Lans et al., 1993; Brouwer et al., 1998; Kato et al., 2004) , displacement of T 4 from serum TTR by PB did not occur in PB-treated rats, with the exception of the slight displacement in Wistar rats at 120 min after PB treatment. Accordingly, the decrease in the level of serum T 4 in PB-treated rats occurs in a TTR-independent pathway. In addition, no change in activity of hepatic sulfotransferase, which efficiently catalyzes the sulfation of iodothyronines (Kester et al., 1999) , by PB treatment was observed in either Wistar or Gunn rats.
In conclusion, the present findings demonstrate that the decrease in serum total T 4 level by PB in Gunn rats occurs without increases in hepatic T 4 -metabolizing enzymes (T 4 -UDP-GT, ID-I, and sulfotransferase), the binding of PB to serum TTR, and the level of serum TSH, although an exact mechanism for the PB-induced decrease remains unclear. In Wistar rats, PB-induced T 4 -UDP-GT might also contribute, in part, to the decrease in serum T 4 level. To clarify the exact mechanisms for the PB-induced decrease in serum thyroid hormones, further studies involving T 4 transporters, nonhepatic T 4 -UDP-GT, and exchangeable thyroid hormone pools in nonhepatic tissues would be necessary.
